Donegan Michael C

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 77% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Donegan Michael C's trades of TherapeuticsMD Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
442.47
Quantity 5,906 -36.5%
Value US$2,240,561
Transaction date
Sale
Price
197.11
Quantity 67,680 -11.7%
Value US$28,343
Transaction date
Sale
Price
92.21
Quantity 69,180 +25.1%
Value US$2,882,975
Transaction date
Sale
Price
5.34
Quantity 1,302 -14.6%
Value US$6,950
Transaction date
Sale
Price
0.54
Quantity 29,790 -23.1%
Value US$15,947
Transaction date
Sale
Price
1.04
Quantity 4,842 -25.5%
Value US$5,036
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-30 2023-01-27
S Sale
5,906 -36.5%
442.47
US$2,240,561 		5,906 -36.5% 442.47 US$2,240,561
2023-01-30 2023-01-26
S Sale
67,680 -11.7%
197.11
US$28,343 		67,680 -11.7% 197.11 US$28,343
2023-01-25 2023-01-24
S Sale
69,180 +25.1%
92.21
US$2,882,975 		69,180 +25.1% 92.21 US$2,882,975
2023-01-25 2023-01-23
S Sale
1,302 -14.6%
5.34
US$6,950 		1,302 -14.6% 5.34 US$6,950
2022-12-09 2022-12-06
S Sale
910 -16.7%
4.78
US$4,345 		910 -16.7% 4.78 US$4,345
2021-12-02 2021-11-30
S Sale
29,790 -23.1%
0.54
US$15,947 		29,790 -23.1% 0.54 US$15,947
2021-05-12 2021-05-11
S Sale
4,842 -25.5%
1.04
US$5,036 		4,842 -25.5% 1.04 US$5,036